Mabwell (Shanghai) Bioscience Co., Ltd. (688062.SS) SHH

Currency In CNY

AD

Valuation

Market Cap15.36B
Enterprise Value16.8B
P/E Ratio-11.71
PEG Ratio-0.57
Price/Sales Ratio12.36
Price/Book Ratio13.27
Enterprise/Revenue13.19
Enterprise/EBITDA-14.23

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin-1.08
Operating Margin-0.97
AD

Management Effectiveness

Return On Assets-0.18
Return On Equity-1.8

Income Statement

Revenue662.52M
Revenue/Share2.04
Gross Profit662.52M
EBITDA-860.38M
Net Income-970.18M
Diluted EPS-2.43

Balance Sheet

Total Cash2.29B
Total Cash/Share5.35
Total Debt2.95B
Total Debt/Equity3.38
Current Ratio1.25
Book Value Per Share2.46

Price History

52-Week Change-42.93
52-Week High49.83
52-Week Low23.85
Moving Average 50 Days29.02
Moving Average 200 Days33.53

Statistics

Average Volume9.91M
Shares Outstanding399.6M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-0.05
Last Split FactorN/A
Last Split DateN/A
AD